We are live on ! Find out more
BCM

Bridgeway Capital Management Portfolio holdings

AUM $4.97B
1-Year Est. Return 44.96%
This Fund
S&P 500
This Quarter Est. Return
+5.04%
1 Year Est. Return
+44.96%
3 Year Est. Return
+114.45%
5 Year Est. Return
+175.29%
10 Year Est. Return
+704.02%
AUM
$9.85B
AUM Growth
+$544M
Cap. Flow
+$305M
Cap. Flow %
3.1%
Top 10 Hldgs %
10.6%
Holding
1,507
New
131
Increased
296
Reduced
233
Closed
100

Top Buys

Rank Stock Value
1
MS icon
Morgan Stanley
MS
+$69.7M
2
WBA
Walgreens Boots Alliance
WBA
+$62.8M
3
EXR icon
Extra Space Storage
EXR
+$62.1M
4
APC
Anadarko Petroleum
APC
+$58.4M
5
CI icon
Cigna
CI
+$58.3M

Top Sells

Rank Stock Value
1
LRCX icon
Lam Research
LRCX
+$70.2M
2
SRE icon
Sempra
SRE
+$62.5M
3
LNC icon
Lincoln National
LNC
+$62.2M
4
XL
XL Group Ltd.
XL
+$60.6M
5
NEE icon
NextEra Energy
NEE
+$58.5M

Sector Composition

Rank Sector Weight
1 Financials 23.55%
2 Industrials 12.89%
3 Consumer Discretionary 12.47%
4 Healthcare 10.29%
5 Technology 10.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MDXG icon
1376
MiMedx Group
MDXG
$602M
$82K ﹤0.01%
12,800
– –
CATX icon
1377
Perspective Therapeutics
CATX
$332M
$80K ﹤0.01%
17,850
– –
SGRP
1378
DELISTED
SPAR Group
SGRP
$79K ﹤0.01%
63,000
+30,000
+91% +$39K
SYPR icon
1379
Sypris Solutions
SYPR
$42.8M
$76K ﹤0.01%
46,404
– –
IRD
1380
Opus Genetics
IRD
$306M
$75K ﹤0.01%
1,106
– –
MXC icon
1381
Mexco Energy
MXC
$17.8M
$72K ﹤0.01%
12,000
– –
MOC
1382
DELISTED
Command Security Corporation
MOC
$69K ﹤0.01%
44,600
– –
ALR
1383
DELISTED
AlerisLife Inc
ALR
$68K ﹤0.01%
4,523
-503
-10% -$6.54K
STKS icon
1384
The ONE Group
STKS
$56.2M
$67K ﹤0.01%
27,400
– –
QUMU
1385
DELISTED
Qumu Corp.
QUMU
$66K ﹤0.01%
30,000
– –
HLTH
1386
DELISTED
Nobilis Health Corp.
HLTH
$66K ﹤0.01%
55,000
+40,000
+267% +$55.4K
CFBK icon
1387
CF Bankshares
CFBK
$234M
$63K ﹤0.01%
4,800
-3,891
-45% -$51.2K
ZDGE icon
1388
Zedge
ZDGE
$38.6M
$63K ﹤0.01%
16,855
– –
AGRX
1389
DELISTED
Agile Therapeutics
AGRX
$60K ﹤0.01%
61
-36
-37% -$126K
TIK
1390
DELISTED
Tel-Instrument Electronics Corp.
TIK
$50K ﹤0.01%
15,000
– –
FLNA
1391
Filana Therapeutics
FLNA
$48.8M
$49K ﹤0.01%
23,922
– –
ASXC
1392
DELISTED
Asensus Surgical, Inc.
ASXC
$49K ﹤0.01%
862
-3,846
-82% -$140K
DCOY
1393
Decoy Therapeutics
DCOY
$2.19M
– –
0
– –
QRHC icon
1394
Quest Resource Holding
QRHC
$26.8M
$43K ﹤0.01%
22,000
– –
GERN icon
1395
Geron
GERN
$828M
$42K ﹤0.01%
12,200
– –
CVM icon
1396
CEL-SCI Corp
CVM
$20.3M
$37K ﹤0.01%
1,333
– –
MDLY
1397
DELISTED
Medley Management Inc
MDLY
$36K ﹤0.01%
1,000
-1,360
-58% -$64.9K
IPAS
1398
DELISTED
Ipass Inc Common Stock
IPAS
$33K ﹤0.01%
9,530
-460
-5% -$1.7K
PZG icon
1399
Paramount Gold Nevada
PZG
$96.1M
$32K ﹤0.01%
25,000
– –
SGLY icon
1400
Singularity Future Technology
SGLY
$4.69M
$26K ﹤0.01%
32
– –
54 55
56
57 58

Similar funds

CFC
Cincinnati Financial Corp Fairfield, Ohio $4.96B AUM 18.21% 1-Year Est. Return
SNT
SIG North Trading Bala Cynwyd, Pennsylvania $4.98B AUM 36.24% 1-Year Est. Return
MA
Marshfield Associates Washington, District of Columbia $4.99B AUM 1.59% 1-Year Est. Return
FFB
First Financial Bankshares Abilene, Texas $4.95B AUM 25.06% 1-Year Est. Return
AM
Atreides Management Boston, Massachusetts $5B AUM 78.34% 1-Year Est. Return
SGM
Skye Global Management West Palm Beach, Florida $5B AUM 11.9% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return
SMFG
Sumitomo Mitsui Financial Group Tokyo, Japan $4.94B AUM 1.39% 1-Year Est. Return

Bridgeway Capital Management's Q2 2018 Portfolio in Review

As of Q2 2018, Bridgeway Capital Management held 1,507 positions worth $9.85B, up 5.8% from $9.31B the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Bridgeway Capital Management deployed $305M of net new capital in Q2 2018, opening 131 new positions and adding to 296 existing holdings. Its largest new stake was Morgan Stanley: 1,333,400 shares worth $63.2M.

By sector, the portfolio is most concentrated in Financials at 24% of assets, up from 23% a quarter earlier, followed by Industrials and Consumer Discretionary.

On the sell side, the largest reduction was Lam Research, an estimated $70.2M trimmed.

  • Bridgeway Capital Management's largest Q2 2018 buy was Morgan Stanley: 1,333,400 shares worth $63.2M.
  • Bridgeway Capital Management added most to Cigna in Q2 2018, an estimated $58.3M increase.
  • Bridgeway Capital Management's biggest Q2 2018 reduction was Lam Research, cutting an estimated $70.2M.
  • Bridgeway Capital Management fully exited Sempra in Q2 2018, selling an estimated $62.5M.
  • Bridgeway Capital Management's ten largest holdings make up 11% of its $9.85B portfolio in Q2 2018.
  • Bridgeway Capital Management opened 131 new positions and closed 100 in Q2 2018.
  • Bridgeway Capital Management's portfolio value rose 5.8% quarter-over-quarter to $9.85B.

Based on Bridgeway Capital Management's 13F filing for Q2 2018, filed 14 Aug 2018.